ArticleMolecular psychiatry2020

5-HT2C receptor blockade reverses SSRI-associated basal ganglia dysfunction and potentiates therapeutic efficacy.

Elena Y Demireva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.